These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21633367)

  • 21. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.
    Nyberg LM; Bias WB; Hochberg MC; Walsh PC
    J Urol; 1982 Jul; 128(1):48-51. PubMed ID: 6980996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peyronie's disease and peripheral neuropathies].
    Diagne M; Gueye SM; Ba M; Konan PG; Diop AG; Ndiaye MM; Ndiaye IP; Mensah A
    Dakar Med; 1998; 43(2):234-7. PubMed ID: 10797972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Peyronie's and Dupuytren's diseases in an individual after single episodes of trauma: a case report and review of the literature.
    Connelly TJ
    J Am Acad Dermatol; 1999 Jul; 41(1):106-8. PubMed ID: 10411420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.
    Mulhall JP; Creech SD; Boorjian SA; Ghaly S; Kim ED; Moty A; Davis R; Hellstrom W
    J Urol; 2004 Jun; 171(6 Pt 1):2350-3. PubMed ID: 15126819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical characteristics of Peyronie's patients with notching deformity.
    Cakan M; Akman T; Oktar T; Gurkan L; Celtik M; Kadioglu A
    J Sex Med; 2007 Jul; 4(4 Pt 2):1174-8. PubMed ID: 17662024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrin deposition in Peyronie's disease plaque.
    Somers KD; Dawson DM
    J Urol; 1997 Jan; 157(1):311-5. PubMed ID: 8976287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the clinical characteristics of Peyronie's disease in young men.
    Deveci S; Hopps CV; O'Brien K; Parker M; Guhring P; Mulhall JP
    J Sex Med; 2007 Mar; 4(2):485-90. PubMed ID: 17081219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is colchicine effective in Peyronie's disease? A pilot study.
    Akkus E; Carrier S; Rehman J; Breza J; Kadioglu A; Lue TF
    Urology; 1994 Aug; 44(2):291-5. PubMed ID: 8048212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review: Dupuytren's disease in Asia and the migration theory of Dupuytren's disease.
    Slattery D
    ANZ J Surg; 2010; 80(7-8):495-9. PubMed ID: 20795961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dupuytren's disease, alcohol consumption and alcoholism.
    Gudmundsson KG; Arngrímsson R; Jónsson T
    Scand J Prim Health Care; 2001 Sep; 19(3):186-90. PubMed ID: 11697563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Etiology of Peyronie's Disease: Pathogenesis and Genetic Contributions.
    Sharma KL; Alom M; Trost L
    Sex Med Rev; 2020 Apr; 8(2):314-323. PubMed ID: 31540807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for Peyronie's disease: a case-control study.
    Bjekic MD; Vlajinac HD; Sipetic SB; Marinkovic JM
    BJU Int; 2006 Mar; 97(3):570-4. PubMed ID: 16469028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetics and immunology of Peyronie's disease.
    Noss MB; Day NS; Christ GJ; Melman A
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S127-32. PubMed ID: 11035400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peyronie's disease in men under age 40: characteristics and outcome.
    Tefekli A; Kandirali E; Erol H; Alp T; Köksal T; Kadioğlu A
    Int J Impot Res; 2001 Feb; 13(1):18-23. PubMed ID: 11313836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Peyronie and Ledderhose Diseases in a Series of 730 Patients with Dupuytren Disease.
    Mohede DCJ; Riesmeijer SA; de Jong IJ; Werker PMN; van Driel MF
    Plast Reconstr Surg; 2020 Apr; 145(4):978-984. PubMed ID: 32221218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological and structural findings supporting the fibromatous origin of dorsal knuckle pads.
    Caroli A; Zanasi S; Marcuzzi A; Guerra D; Cristiani G; Ronchetti IP
    J Hand Surg Br; 1991 Aug; 16(3):258-62. PubMed ID: 1960489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie's disease.
    Patel DP; Christensen MB; Hotaling JM; Pastuszak AW
    World J Urol; 2020 Feb; 38(2):253-261. PubMed ID: 31190155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epidemiology of Dupuytren's Disease in Korea: a Nationwide Population-based Study.
    Lee KH; Kim JH; Lee CH; Kim SJ; Jo YH; Lee M; Choi WS
    J Korean Med Sci; 2018 Jul; 33(31):e204. PubMed ID: 30069170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction.
    Kadioglu A; Oktar T; Kandirali E; Kendirci M; Sanli O; Ozsoy C
    Int J Impot Res; 2004 Dec; 16(6):540-3. PubMed ID: 15116064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.